E
Orchestra BioMed Holdings, Inc. OBIO
$2.60 $0.051.96% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -25.41% -28.41% -24.23% -25.26% -29.19%
Total Depreciation and Amortization 11.34% 9.31% 7.32% 3.86% 8.58%
Total Amortization of Deferred Charges 215.38% 1.32% -72.32% -97.93% -73.10%
Total Other Non-Cash Items 39.92% 64.98% 84.58% 84.82% 73.23%
Change in Net Operating Assets -251.90% 110.90% 76.87% 115.56% 150.63%
Cash from Operations -33.21% -20.51% -9.61% -9.33% -9.07%
Capital Expenditure -144.27% -670.59% -270.51% -33.33% 61.47%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -56.68% -64.71% 29.87% 158.54% 163.36%
Cash from Investing -58.07% -66.33% 22.48% 158.24% 163.01%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 4,286.42% 5,780.46% 5,913.78% 15,124.75% -99.69%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -100.98% -100.00% -100.00%
Cash from Financing 369.05% 372.54% -36.88% -91.26% -121.30%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -167.96% -207.50% -177.01% 108.38% 108.07%